needle free injection vaccine breakthrough, page-11

The whole company currently only has a market capitalisation of $20m. It seems to me that just the veterinary market alone for a unique product like this that will make vaccinating large herds of animals faster, safer, easier and a lot more cost efficient. It would be worth a whole lot more than $20m to a large pharmaceutical co who could charge premium prices for such a unique product imo.

There now seems to be no impediment to it's use on animals.

Then there is the possibility of the human market....